ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SPNC The Spectranetics Corp. (MM)

38.45
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
The Spectranetics Corp. (MM) NASDAQ:SPNC NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 38.45 38.45 38.50 0 01:00:00

Spectranetics to Participate in Upcoming Investor Conferences

30/04/2015 9:01pm

GlobeNewswire Inc.


The Spectranetics Corp. (MM) (NASDAQ:SPNC)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more The Spectranetics Corp. (MM) Charts.

The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be participating in two upcoming investor conferences.

Spectranetics management is scheduled to present at the 2015 Bank of America Merrill Lynch Healthcare Conference in Las Vegas on Thursday, May 14, 2015 at 10:40 am PT. Interested parties can access the live audio webcast at http://www.spectranetics.com. An archived presentation will be available on the website for 30 days.

Spectranetics management is also scheduled to participate in the 12th Annual Craig-Hallum Institutional Investor Conference in Minneapolis on Wednesday, May 27, 2015.

About Spectranetics

SPNC develops, manufactures, markets and distributes medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are sold in over 65 countries and are used to treat arterial blockages in the heart and legs and in the removal of pacemaker and defibrillator leads.

The Company's Vascular Intervention (VI) products include a range of laser catheters for ablation of blockages in arteries above and below the knee as well as the AngioSculpt(R) scoring balloon used in both peripheral and coronary procedures. The Company also markets support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions. The Company markets aspiration and cardiac laser catheters to treat blockages in the heart.

The Lead Management (LM) product line includes excimer laser sheaths, dilator sheaths, mechanical sheaths and accessories for the removal of pacemaker and defibrillator cardiac leads.

For more information, visit www.spectranetics.com.

CONTACT: COMPANY CONTACT
         The Spectranetics Corporation
         Guy Childs, Chief Financial Officer
         (719) 633-8333
         
         INVESTOR CONTACTS
         Westwicke Partners
         Lynn Pieper
         (415) 202-5678
         lynn.pieper@westwicke.com

1 Year The Spectranetics Corp. (MM) Chart

1 Year The Spectranetics Corp. (MM) Chart

1 Month The Spectranetics Corp. (MM) Chart

1 Month The Spectranetics Corp. (MM) Chart

Your Recent History

Delayed Upgrade Clock